Halozyme Therapeutics, Inc. (HALO)
NASDAQ·Healthcare·Biotechnology
$69.64
-1.53%
Mkt Cap $8.48B
Analyst Ratings
Buy
5
Hold
1
Sell
0
Price Target (19 analysts)
$73.83
Range $56.00 – $94.00
Implied Upside
+6.0%
Consensus $73.83 vs current $69.64
NASDAQ·Healthcare·Biotechnology
$69.64
-1.53%
Mkt Cap $8.48B
Buy
5
Hold
1
Sell
0
Price Target (19 analysts)
$73.83
Range $56.00 – $94.00
+6.0%
Consensus $73.83 vs current $69.64